申请人:THE WELLCOME FOUNDATION LIMITED
公开号:EP0022578A1
公开(公告)日:1981-01-21
Heterocyclic compounds of formula (I)
and their acid addition salts exhibit anti-inflammatory activity and when administered topically do not provide the side-effects associated with their systemic administration. The novel compounds of formula (I) may be prepared by methods known in the art and may be topically administered as the compound alone or in a suitable pharmaceutical formulation.
式 (I) 的杂环化合物
及其酸加成盐具有抗炎活性,局部用药时不会产生与全身用药相关的副作用。式(I)的新型化合物可通过本领域已知的方法制备,并可作为化合物单独或在合适的药物制剂中局部给药。